EP3209647
Kristallaform af 5-klóró-N4-[-2-(dímetýlfosfórýl)fenýl]-N2-{2-metoxý-4-[4-(4-metýlpíperasín-1-ýl)píperidín-1-ýl]pýrimidín-2,4-díamíni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
21.10.2015EP published:
3.6.2020EP application number:
15787846.3
EP translation filed:
24.8.2020Grant published:
15.9.2020EPO information:
European Patent Register
Max expiry date:
20.10.2035Expiry date:
20.10.2026Next due date:
31.10.2026
Title:
CRYSTALLINE FORMS OF 5-CHLORO-N4-[-2-(DIMETHYLPHOSPHORYL) PHENYL]-N2-{2-METHOXY-4-[4-(4-METHYLPIPERAZIN-1-YL) PIPERIDIN-1-YL]PYRIMIDINE-2,4-DIAMINE
Timeline
Today
21.10.2015EP application
3.6.2020EP Publication
24.8.2020Translation submitted
15.9.2020Registration published
20.10.2026Expires
Owner
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka, JP
Inventor
Name:
ROZAMUS, Leonard, W.Address:
Andover, MA 01810, US
Name:
SHARMA, PradeepAddress:
Westford, MA 01886, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201462066849 PDate:
21.10.2014Country:
US
Classification
Categories:
C07D 239/48, A61K 31/506, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 21.8.2020
Expires: 20.10.2021
Payer: Patice ehf.
Number: 7
Paid: 1.10.2021
Expires: 20.10.2022
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 20.9.2022
Expires: 20.10.2023
Payer: Patice ehf.
Number: 9
Paid: 6.10.2023
Expires: 20.10.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 23.9.2024
Expires: 20.10.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 14.10.2025
Expires: 20.10.2026
Payer: Árnason Faktor ehf.